sameAs
Taxonomic position and phylogeny of the genus Vargasiella (Orchidaceae, Vandoideae) based on molecular and morphological evidenceNutrition and Vascular Supply of Retinal Ganglion Cells during Human DevelopmentTrametinib: a MEK inhibitor for management of metastatic melanomaFollow-up in soft tissue sarcomasFollow-up in melanoma patientsThe outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.Improved overall survival in melanoma with combined dabrafenib and trametinib.ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016Current status and unanswered questions on the use of Denosumab in giant cell tumor of boneMelanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trialCombined Nivolumab and Ipilimumab or Monotherapy in Untreated MelanomaImproved survival with MEK inhibition in BRAF-mutated melanomaNivolumab in previously untreated melanoma without BRAF mutationSurgery of primary melanomas.Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression.A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.Other targetable sarcomas.Epidermal growth factor receptor (EGFR) status in chordoma.Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.Results of systemic treatment of cutaneous melanoma in inoperable stage III and IVClinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib.Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma.Taxonomy of Cyrtochilum-alliance (Orchidaceae) in the light of molecular and morphological data.Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumorsMolecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications.Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection.Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.Current treatment options for dermatofibrosarcoma protuberans.Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age
P50
Q15429772-1C836491-9D90-478B-9F9C-940A755171B6Q15429859-CDFA6016-4631-4F8A-9393-778EC2488EBBQ15441566-D0C1409A-5509-4124-9F34-F4F5EBD2C8DDQ15441708-16DAB85C-CB9F-447A-B734-FDC918E87CCBQ15441826-F2275CA7-CC0E-4D27-9C9D-05E5258A8448Q15442432-7283B212-B044-414E-85A2-A05BC7E61F3DQ15447684-9B9FA5DF-2567-40AD-93FA-CE7FA30511BAQ15451655-8DCF6F6E-B460-4F0E-905A-CEF20AC9F904Q15459836-9F649388-D14B-471A-A3DF-40CFBEB10FB3Q15461020-B15FA2A8-DBBA-40E2-A7BF-E38BF7CB375EQ15462508-05198BE8-3935-45EA-B704-DF0ABD5D4F49Q15467833-2A0B9A24-A8B9-4232-97C6-EAF0426F6256Q15471257-7AF28128-3130-43C6-B88E-B8665A1AF0C1Q15473711-B242511E-33DC-4DBA-A8B5-1697C6C2ABC5Q15482307-F975FDEA-983A-4391-97A9-50FEEF76A2D7Q15490037-43D338EA-B9CC-46D3-854D-C546EE1EEAB7Q15490965-f4e6fe1a-4b80-b13f-0435-ba67976c3cd0Q15491625-AC83E9A8-0593-4328-93BE-416E8EC40C2EQ15492403-D0015D49-5504-42E2-8A5F-EA901E0D3723Q15492420-24E5912B-F39F-4300-8801-8C72D8AC4D77Q15492883-C166D965-5C0B-4DF7-9E00-D9F88704B787Q15495065-B4E7516E-4764-4885-A412-E9DFBAFDA8A0Q15495856-77F6CE3F-4B63-4AE8-81D2-0A8CF5E94489Q15496130-BF9F8692-4A07-4B7A-B5A2-C0D2FB37C17DQ15496473-21F00D56-9CED-4EFF-B8F8-16A2C3E83DB8Q15497361-97DA3D0D-61FF-4277-92BA-265E0001F769Q15501078-4A2FF57E-CA60-425A-8F85-1575A0A6F184Q15977829-0fd3ff75-47aa-a1ac-3b19-23d603f6e314Q17270073-E2093A1A-46E2-4EF2-956A-FBC4B73FC00DQ17320419-260B6F66-7231-4AFE-BE0F-D027E68457B4Q17320420-A7CE9D5D-F20C-43E8-93E5-C5E1F392E51AQ17328122-5954A1F3-9DC4-47AC-A6A7-1D60510F0F68Q17329551-48C4D5C5-2C30-4996-8F33-EAE33587EB0AQ17329552-0C41CB26-7EC9-4C7D-B89A-00725DDE4A3BQ42890044-A23F85CE-84DC-409C-90ED-A2A34E324027Q42890087-710CB3A8-1553-4B00-90F9-FCDD827D312EQ42893415-6F7B7C4A-9A0A-4D1E-B57B-FDFAB9C74B45Q43025234-b4a9adf7-4d50-1a37-203c-1b617f4c6fcbQ43041513-2F7EC9D9-9FC7-4C98-82DE-9C70743378DDQ5488203-4BCE93B4-42D0-4A83-9E5A-1201CAEA94DC
P405
Q21132029-D95B8C81-AB28-4E78-A4AA-0FE58AE8A4C4Q26752557-B5525DBB-71D9-4BAF-B748-A617CA6F357AQ26782976-83AAD6C3-E1BE-46BD-BE88-BA18B7597E5CQ26830942-189CA7C9-823A-4B42-9563-4F21981839D6Q26999904-A0D37268-97E7-4F77-A399-986BB23EFDEDQ27851744-93BA0F22-691A-4D22-9917-898B508BB76CQ27853091-CFF907B9-31A5-4C7E-9A55-D2A71D660CDBQ27928062-E368658A-4DEE-4808-B23B-6DB820740ED5Q28066533-E7AE17B6-90AD-44B6-B48C-DC9710F66199Q28553228-D9BF38FB-2B8D-4472-808C-6A938E58D7C6Q29614756-8337CC2F-7E04-479E-8B69-315CF3AD9657Q29615443-6FA1C0AE-6E5B-49C9-BDF6-FE8562D76F87Q29620663-20C0585D-0650-489F-A4EB-6BF22A982020Q29620688-C7CD023C-9BF8-439B-B578-154C87457420Q30356095-EF221FEE-8FF3-4456-AC84-C7ECD6D95A8EQ30923563-E1B6A517-60FD-4D2A-B0E8-71D6A87963E1Q33168544-50390012-4A13-417B-AA30-6F5330BCED45Q33273478-86C50595-E597-4147-B7B8-45392142A60DQ33273569-13CB2ADA-2696-48C8-B55B-924E38F6B5F9Q33276384-CEAA9753-CC12-47E4-9C52-D1CB7E62B9BFQ33394167-80F003A2-C3FE-418E-B27C-273F41127883Q33408564-1A2D1123-54F3-4FDE-A176-3CEA3372DC99Q33420123-1A0DA584-906A-43AB-BCD0-8C895130D817Q33440103-B0554FBB-A926-4B67-B20F-27EE74AB36F2Q33681651-54745918-3A23-425F-B0E2-35971FE6A3EBQ33777447-2565A3B4-65E3-4287-ACDC-AD4BF995BC12Q33778554-E76173C7-390F-4A73-BFBF-62F733BDB405Q33881765-24F6BF8E-4F76-4039-B6A3-E496E91F9E0FQ33992622-916FB224-8C9A-4CA1-B542-58282D824A1DQ34372934-D0B158DC-9108-4926-B2A5-CD9F60DBF309Q34409481-F57D941B-A378-4162-BE27-4A5074554828Q34446657-D7145393-0CC8-4243-8880-DFFAABF1DE8EQ34578454-EFC43E61-84F6-47F6-A8F5-19BDDEF3598BQ34620856-46033D9B-ED62-4D2F-934C-988619DCCE6FQ34636081-A83ECBEA-3532-4886-95D6-38CE4614508FQ34645665-835EF5F2-A8EA-470E-BB2B-500021A27F8EQ34670080-635C6C5D-8DC8-4121-BF66-F2A186F66DFAQ34982581-61B9E6B2-FD51-460C-BCAF-39809628ADD2Q35214578-F8017976-CCB6-4E8F-AE57-79343C5FDC56Q35350491-FF1388BB-D5FD-4FD4-BE2D-41337FF7E6E6
P50
description
Pools botanicus
@nl
botanico polacco
@it
botanikari poloniarra
@eu
botanist
@en
botaniste polonais
@fr
botànic polonès
@ca
botánico polaco
@es
botánico polaco
@gl
botánicu polacu
@ast
botânico polaco
@pt
name
Piotr Rutkowski
@ast
Piotr Rutkowski
@ca
Piotr Rutkowski
@de
Piotr Rutkowski
@en
Piotr Rutkowski
@es
Piotr Rutkowski
@fr
Piotr Rutkowski
@ga
Piotr Rutkowski
@nl
Piotr Rutkowski
@pl
Piotr Rutkowski
@sl
type
label
Piotr Rutkowski
@ast
Piotr Rutkowski
@ca
Piotr Rutkowski
@de
Piotr Rutkowski
@en
Piotr Rutkowski
@es
Piotr Rutkowski
@fr
Piotr Rutkowski
@ga
Piotr Rutkowski
@nl
Piotr Rutkowski
@pl
Piotr Rutkowski
@sl
altLabel
Rutk.
@bg
Rutk.
@de
Rutk.
@en
Rutk.
@it
Rutk.
@ru
prefLabel
Piotr Rutkowski
@ast
Piotr Rutkowski
@ca
Piotr Rutkowski
@de
Piotr Rutkowski
@en
Piotr Rutkowski
@es
Piotr Rutkowski
@fr
Piotr Rutkowski
@ga
Piotr Rutkowski
@nl
Piotr Rutkowski
@pl
Piotr Rutkowski
@sl
P1015
P214
P269
P101
P1015
P106
P1207
P1412
P1695
P21
P213
0000 0001 1246 0926
P214
P269
P27
P31
P4081
P496
0000-0002-8920-5429
P569
1969-01-01T00:00:00Z